Status:
COMPLETED
Biphasic Calcium Phosphate vs. Hydroxyapatite in Sinus Floor Elevation
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
Dentsply Sirona Implants and Consumables
Conditions:
Bone Substitutes
Calcium Phosphates
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Twenty patients scheduled for lateral-window sinus floor Elevation (SFE) are randomized into two groups: use of SYMBIOS® Biphasic Bone Graft Material (Group 1) or of Algipore® Bone Substitution Materi...
Eligibility Criteria
Inclusion
- Capability of giving an informed consent
- Good health as defined by the subject's medical history
- Patients age 20-75 years
- Fully edentulous or partially edentulous patients with unilateral or bilateral missing teeth in the maxillary premolar or molar areas with severe alveolar atrophy and a residual alveolar ridge height of maximal 5 mm requiring a two-staged sinus floor elevation and implant placement.
Exclusion
- Patients without detailed baseline medical data
- Patients with medical history of local inflammations in the posterior maxilla
- Skeletal immaturity
- Patients with osteoporosis in their medical history
- Patients with severe illnesses, malignant diseases, radiotherapy or chemotherapy in their medical history
- Patients with pathological fractures
- Patients treated with bisphosphonates
- Uncontrolled diabetes mellitus
- Uncontrolled periodontal diseases
- Smoking
- Pregnancy
Key Trial Info
Start Date :
February 23 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 28 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04331314
Start Date
February 23 2015
End Date
October 28 2019
Last Update
April 2 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.